|
(2R)-2-hydroxynaringenin
|
142229 |
|
|
(2R)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine
|
92217 |
|
|
(2R)-CDP-glycerol
|
132202 |
|
|
(2R,3S,2′R,3′R)-2,3,2′,3′-tetrahydroxy-beta,beta-caroten-4-one
|
224061 |
|
|
(2R)-N-{(1S,2R,3E,7E)-1-[(beta-D-glucopyranosyloxy)methyl]-2-hydroxy-8-methylhexadeca-3,7-dien-1-yl}-2-hydroxyoctadecanamide
|
227125 |
|
|
(2R*,4R*)-3,4-dihydro-5-methoxy-2-methyl-2H-1-benzopyran-4-OL
|
220031 |
|
|
(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile
|
126422 |
|
|
(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-2-azetidinecarbonitrile
|
99222 |
|
|
(2R,3R,4S)-1-(2-fluorobenzoyl)-4-(hydroxymethyl)-3-phenylazetidine-2-carbonitrile
|
97226 |
|
|
(2R,3S)-2,3-dimethylmalate(2-)
|
57422 |
|
|
(2R,3S,2'S)-nadolol
|
60922 |
|
|
(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
|
99224 |
|
|
(2R,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
|
100228 |
|
|
(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
|
130220 |
|
|
(2R,3S,4S)-2,3,4,8-tetrahydroxy-3,4-dihydro-2H-naphthalen-1-one
|
223720 |
|
